FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308527956> ?p ?o ?g. }

• W4308527956 endingPage "494" @default.
• W4308527956 startingPage "482" @default.
• W4308527956 abstract "Abstract Aims/hypothesis Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m 2 ) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes. Methods We assessed the prospective association between annually recorded measures of eGFR and UACR and the occurrence of myocardial infarction (MI), CHD, stroke, heart failure (HF) and cardiovascular mortality in 13,657 individuals with diabetes (53.6% male, age 62.3±12.1 years) from the Hoorn Diabetes Care System cohort, using data obtained between 1998 and 2018. Multivariate time-dependent Cox regression models adjusted for cardiovascular risk factors were used to estimate HRs and 95% CI. Associations of eGFR were adjusted for UACR values and vice versa. Effect modification by sex was investigated for all associations. Results After a mean follow-up period of 7 years, event rates per 1000 person-years were 3.08 for MI, 3.72 for CHD, 1.12 for HF, 0.84 for stroke and 6.25 for cardiovascular mortality. Mildly reduced eGFR (60–90 ml/min per 1.73 m 2 ) and moderately to severely reduced eGFR (<59 ml/min per 1.73 m 2 ) were associated with higher risks of MI (HR 1.52; 95% CI 1.10, 2.12 and HR 1.69; 95% CI 1.09, 2.64) and CHD (HR 1.67; 95% CI 1.23, 2.26 and HR 2.01; 95% CI 1.34, 3.02) compared with normal eGFR (>90 ml/min per 1.73 m 2 ). Mildly reduced eGFR was associated with a higher risk of stroke (HR 2.53; 95% CI 1.27, 5.03). Moderately increased UACR (3–30 mg/mmol) and severely increased UACR (>30 mg/mmol) were prospectively associated with a higher cardiovascular mortality risk in men and women (HR 1.87; 95% CI 1.41, 2.47 and HR 2.78; 95% CI 1.78, 4.34) compared with normal UACR (<3 mg/mmol). Significant effect modification by sex was observed for the association between UACR and HF. Because there were a limited number of HF events within the category of UACR >30 mg/mmol, categories were combined into UACR <3.0 and >3.0 mg/mmol in the stratified analysis. Women but not men with UACR >3.0 mg/mmol had a significantly higher risk of HF compared with normal UACR (HR 2.79; 95% CI 1.47, 5.28). Conclusions/interpretation This study showed differential and independent prospective associations between manifestations of early kidney damage in diabetes and several CVD subtypes, suggesting that regular monitoring of both kidney function measures may help to identify individuals at higher risk of specific cardiovascular events. Graphical abstract" @default.
• W4308527956 created "2022-11-12" @default.
• W4308527956 creator A5012034837 @default.
• W4308527956 creator A5012526668 @default.
• W4308527956 creator A5016713750 @default.
• W4308527956 creator A5019357383 @default.
• W4308527956 creator A5039341334 @default.
• W4308527956 creator A5054193238 @default.
• W4308527956 creator A5089616773 @default.
• W4308527956 date "2022-11-08" @default.
• W4308527956 modified "2023-09-26" @default.
• W4308527956 title "Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort" @default.
• W4308527956 cites W1570583414 @default.
• W4308527956 cites W1783757125 @default.
• W4308527956 cites W1988636409 @default.
• W4308527956 cites W1990635289 @default.
• W4308527956 cites W2011049759 @default.
• W4308527956 cites W2068906908 @default.
• W4308527956 cites W2096875294 @default.
• W4308527956 cites W2097805169 @default.
• W4308527956 cites W2111663222 @default.
• W4308527956 cites W2114598208 @default.
• W4308527956 cites W2161569030 @default.
• W4308527956 cites W2166074631 @default.
• W4308527956 cites W2402841512 @default.
• W4308527956 cites W2405585158 @default.
• W4308527956 cites W2460699727 @default.
• W4308527956 cites W2475261460 @default.
• W4308527956 cites W2615714795 @default.
• W4308527956 cites W2621728603 @default.
• W4308527956 cites W2740555108 @default.
• W4308527956 cites W2767001049 @default.
• W4308527956 cites W2775056555 @default.
• W4308527956 cites W2776569781 @default.
• W4308527956 cites W2852231730 @default.
• W4308527956 cites W2861366762 @default.
• W4308527956 cites W2870743986 @default.
• W4308527956 cites W2887185538 @default.
• W4308527956 cites W2913705661 @default.
• W4308527956 cites W2983452894 @default.
• W4308527956 cites W3014917192 @default.
• W4308527956 cites W4211140718 @default.
• W4308527956 cites W4226390647 @default.
• W4308527956 doi "https://doi.org/10.1007/s00125-022-05826-y" @default.
• W4308527956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36347992" @default.
• W4308527956 hasPublicationYear "2022" @default.
• W4308527956 type Work @default.
• W4308527956 citedByCount "0" @default.
• W4308527956 crossrefType "journal-article" @default.
• W4308527956 hasAuthorship W4308527956A5012034837 @default.
• W4308527956 hasAuthorship W4308527956A5012526668 @default.
• W4308527956 hasAuthorship W4308527956A5016713750 @default.
• W4308527956 hasAuthorship W4308527956A5019357383 @default.
• W4308527956 hasAuthorship W4308527956A5039341334 @default.
• W4308527956 hasAuthorship W4308527956A5054193238 @default.
• W4308527956 hasAuthorship W4308527956A5089616773 @default.
• W4308527956 hasBestOaLocation W43085279561 @default.
• W4308527956 hasConcept C126322002 @default.
• W4308527956 hasConcept C127413603 @default.
• W4308527956 hasConcept C134018914 @default.
• W4308527956 hasConcept C159641895 @default.
• W4308527956 hasConcept C164705383 @default.
• W4308527956 hasConcept C188816634 @default.
• W4308527956 hasConcept C201903717 @default.
• W4308527956 hasConcept C207103383 @default.
• W4308527956 hasConcept C2777180221 @default.
• W4308527956 hasConcept C2778653478 @default.
• W4308527956 hasConcept C2780306776 @default.
• W4308527956 hasConcept C2780645631 @default.
• W4308527956 hasConcept C44249647 @default.
• W4308527956 hasConcept C500558357 @default.
• W4308527956 hasConcept C50382708 @default.
• W4308527956 hasConcept C555293320 @default.
• W4308527956 hasConcept C71924100 @default.
• W4308527956 hasConcept C72563966 @default.
• W4308527956 hasConcept C78519656 @default.
• W4308527956 hasConceptScore W4308527956C126322002 @default.
• W4308527956 hasConceptScore W4308527956C127413603 @default.
• W4308527956 hasConceptScore W4308527956C134018914 @default.
• W4308527956 hasConceptScore W4308527956C159641895 @default.
• W4308527956 hasConceptScore W4308527956C164705383 @default.
• W4308527956 hasConceptScore W4308527956C188816634 @default.
• W4308527956 hasConceptScore W4308527956C201903717 @default.
• W4308527956 hasConceptScore W4308527956C207103383 @default.
• W4308527956 hasConceptScore W4308527956C2777180221 @default.
• W4308527956 hasConceptScore W4308527956C2778653478 @default.
• W4308527956 hasConceptScore W4308527956C2780306776 @default.
• W4308527956 hasConceptScore W4308527956C2780645631 @default.
• W4308527956 hasConceptScore W4308527956C44249647 @default.
• W4308527956 hasConceptScore W4308527956C500558357 @default.
• W4308527956 hasConceptScore W4308527956C50382708 @default.
• W4308527956 hasConceptScore W4308527956C555293320 @default.
• W4308527956 hasConceptScore W4308527956C71924100 @default.
• W4308527956 hasConceptScore W4308527956C72563966 @default.
• W4308527956 hasConceptScore W4308527956C78519656 @default.
• W4308527956 hasFunder F4320321007 @default.
• W4308527956 hasFunder F4320321642 @default.
• W4308527956 hasIssue "3" @default.

• next